Abstract
Brazil Drug Delivery Devices Investment Opportunities, Analysis and Forecasts
to 2012
Summary
This report is an essential source for in-depth information and data relating
to the Brazil drug delivery devices market. It also offers detailed and
comprehensive coverage of market revenue, volume, distribution and company
share information; and latest news, financial deals and pipeline products
information of each of the key sub-segments of the drug delivery devices in
Brazil.
Scope
・ The report provides drug delivery devices information broken down into
detailed categories and segments in Brazil.
・ Total revenues, products
sold, end users, and average pricing.
・ Market shares of all the key
competitors.
・ Key pipeline products that are set to shape the market,
broken down by sector.
・ Information on the top medical equipment
companies in the sector in the country covering business description,
strategic analysis, and financial information.
・ Healthcare structure,
regulatory environment, approval process, pricing trends and
reimbursement.
・ Product and brand updates, strategy changes, R&D
projects, corporate expansions and contractions and regulatory changes.
・
Key mergers and acquisitions, partnerships, private equity investments and
IPOs.
・ Customer, hospitals and physicians data.
Reasons to buy
・ Gain a strong understanding of the drug delivery devices market in
Brazil.
・ Evaluate and compare the attractiveness of the market in the
country.
・ Identify growth segments and opportunities in each industry
sector within the country.
・ Evaluate the pipeline of key products that
will change the sector, and identify threats and opportunities before the
products are launched in the country.
・ Analyze the competitiveness of the
market in the country and identify hotspots.
・ Develop strategies based
on the latest product, brand, expansion and research and development news in
the country.
・ Do deals with an understanding of how competitors are
financed, and the mergers and partnerships that have shaped the market in the
country.
・ Identify and analyze the strengths and weaknesses of the
industry incumbents in the country.
Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 12
2 Introduction 14
2.1 What Is This Report About? 14
2.2 Definitions
14
2.2.1 Drug delivery devices 14
2.2.1.1 Needle-free Injections
14
2.2.1.2 Inhalation Systems 14
2.2.1.3 Infusion Systems 15
3
Healthcare Sector Review 16
3.1 Healthcare Expenditure 16
3.2
Healthcare Infrastructure 17
3.3 Healthcare Policy 17
4 Drug Delivery
Devices in Brazil 18
4.1 Drug Delivery Devices Overall Revenues
(2000-2012) 18
4.2 Drug Delivery Devices Overall Volume (2000-2012) 24
4.3 Drug Delivery Devices Company Shares (2005-2006) 27
5 Inhalation
Systems in Brazil 28
5.1 Inhalation Systems Overall Revenues (2000-2012)
28
5.1.1 Metered Dose Inhaler Devices Overall Revenues (2000-2012) 32
5.1.2 Dry Powder Inhaler Devices Overall Revenues (2000-2012) 34
5.2
Inhalation Systems Overall Volume (2000-2012) 36
5.2.1 Metered Dose
Inhaler Devices Overall Volume (2000-2012) 38
5.2.2 Dry Powder Inhaler
Devices Overall Volume (2000-2012) 40
5.3 Inhalation Systems Average Price
(2000-2012) 42
5.3.1 Metered Dose Inhaler Devices Average Price
(2000-2012) 42
5.3.2 Dry Powder Inhaler Devices Average Price (2000-2012)
44
5.4 Inhalation Systems Distribution Share (2005-2006) 46
5.5
Inhalation Systems Company Share (2005-2006) 47
6 Infusion Systems in
Brazil 48
6.1 Infusion Systems Overall Revenues (2000-2012) 48
6.1.1
Infusion Disposable Sets Overall Revenue (2000-2012) 52
6.1.2 Infusion
Pumps Overall Revenue (2000-2012) 54
6.1.3 Syringe Pumps Overall Revenues
(2000-2012) 56
6.2 Infusion Systems Overall Volume (2000-2012) 58
6.2.1 Infusion Disposables Sets Overall Volume (2000-2012) 59
6.2.2
Infusion Pumps Overall Volume (2000-2012) 61
6.2.3 Syringe Pumps Overall
Volume (2000-2012) 63
6.3 Infusion Systems Average Price (2000-2012)
65
6.3.1 Infusion Pumps Average Price (2000-2012) 65
6.3.2 Syringe
Pumps Average Price (2000-2012) 67
6.3.3 Infusion Disposable Sets Average
Price (2000-2012) 69
6.4 Infusion Systems Distribution Share (2005-2006)
71
6.5 Infusion Systems Company Share (2005-2006) 72
7 AstraZeneca PLC
Company Profile 73
7.1 Company Overview 73
7.2 Business Overview
73
7.2.1 Products 75
7.2.2 History 76
7.3 Locations And
Subsidiaries 77
8 3M Company Profile 79
8.1 Company Overview 79
8.2 Business Overview 79
8.2.1 Consumer and Office 79
8.2.1.1 Overview
79
8.2.1.2 Capital Expenditure 79
8.2.1.3 Market View 79
8.2.1.4
Key Strategies 79
8.2.2 Display and Graphics 79
8.2.2.1 Overview
80
8.2.2.2 Financials 80
8.2.2.3 Capital Expenditure 80
8.2.2.4
Market View 80
8.2.2.5 Key Strategies 80
8.2.3 Electro and
Communications 80
8.2.3.1 Overview 80
8.2.3.2 Financials 80
8.2.3.3 Capital Expenditure 80
8.2.3.4 Market View 80
8.2.3.5 Key
Strategies 81
8.2.4 Health Care 81
8.2.4.1 Overview 81
8.2.4.2
Financials 81
8.2.4.3 Capital Expenditure 81
8.2.4.4 Market View
81
8.2.4.5 Key Strategies 82
8.2.5 Industrial and Transportation
82
8.2.5.1 Overview 82
8.2.5.2 Financials 82
8.2.5.3 Capital
Expenditure 82
8.2.5.4 Market View 82
8.2.5.5 Key Strategies 82
8.2.6 Safety, Security and Protection Services 82
8.2.6.1 Overview 82
8.2.6.2 Financials 83
8.2.6.3 Capital Expenditure 83
8.2.6.4 Market
View 83
8.2.6.5 Key Strategies 83
8.2.7 Products 83
8.3 Value
Chain Analysis 85
8.3.1 Manufacturing 85
8.3.1.1 In House
Manufacturing 85
8.3.2 Product Development 85
8.3.2.1 Regulatory
Approvals 85
8.3.2.2 Clinical Trials 86
8.3.2.3 Research and
Development 86
8.3.3 Sales and Marketing 86
8.3.3.1 Partnerships and
Alliances 86
8.3.3.2 Licensing Agreements 86
8.3.3.3 E-distribution
86
8.4 SWOT Analysis 87
8.4.1 3M Company Strengths 87
8.4.1.1
Strong performance of Industrial and Transportation segment 87
8.4.1.2
Focused research and development 87
8.4.1.3 Decentralized operations
88
3M Company Weaknesses 88
8.4.1.4 Increased operating costs in the
U.S. 88
8.4.1.5 Personal care segment' s poor performance 88
3M Company
Opportunities 88
8.4.1.6 Expanding global presence 88
8.4.1.7 The
liquid crystal display 88
8.4.1.8 Enhancing brand portfolio 89
3M
Company Threats 89
8.4.1.9 Foreign currency fluctuations 89
8.4.1.10
Increasing cost of raw materials 89
8.4.1.11 Trend for private labels
89
8.5 Revenue Analysis 89
8.5.1 Revenue by Segment 90
8.5.2
Revenue by Geography 90
8.6 Financial and Operational Review 92
8.6.1
Financial Statements 92
8.6.2 Financial Ratios 93
8.7 Locations And
Subsidiaries 94
9 Baxter International Company Profile 95
9.1 Company
Overview 95
9.2 Business Overview 95
9.2.1 BioScience 95
9.2.1.1
Overview 95
9.2.1.2 Financials 95
9.2.1.3 Capital Expenditure 95
9.2.2 Medication Delivery 95
9.2.2.1 Overview 95
9.2.2.2 Financials
96
9.2.2.3 Capital Expenditure 96
9.2.3 Renal 96
9.2.3.1 Overview
96
9.2.3.2 Financials 96
9.2.3.3 Capital Expenditure 96
9.2.4
Products 97
9.2.5 History 97
9.3 Value Chain Analysis 100
9.3.1
Manufacturing 100
9.3.1.1 In House Manufacturing 100
9.3.2 Product
Development 100
9.3.2.1 Regulatory Approvals 100
9.3.2.2 Clinical
Trials 101
9.3.2.3 Research and Development 101
9.3.3 Sales and
Marketing 101
9.3.3.1 Partnerships and Alliances 101
9.4 SWOT Analysis
102
9.4.1 Baxter International Inc. Strengths 102
9.4.1.1 Diversified
geographic presence 102
9.4.1.2 Sturdy research and development activities
102
9.4.1.3 Strong financial performance 103
9.4.2 Baxter
International Inc. Weaknesses 103
9.4.2.1 High levels of inventory 103
9.4.2.2 Decline in revenues of medication delivery 103
9.4.2.3 Reduced
capital expenditure 103
9.4.3 Baxter International Inc. Opportunities
103
9.4.3.1 Co-developing alliances 103
9.4.3.2 Increasing End Stage
Renal Disease patients 104
9.4.3.3 FDA approval 104
9.4.4 Baxter
International Inc. Threats 104
9.4.4.1 Legal proceedings 104
9.4.4.2
Patent litigation 104
9.4.4.3 Stringent regulations 104
9.5 Revenue
Analysis 105
9.5.1 Revenue by Segment 105
9.5.2 Revenue by Geography
106
9.6 Financial and Operational Review 107
9.6.1 Financial
Statements 107
9.6.2 Financial Ratios 108
9.7 Locations And
Subsidiaries 109
9.8 Baxter International Inc. Pipeline Products 111
9.8.1 Next-Generation Home Hemodialysis Machine 111
9.8.1.1 Product
Overview 111
9.8.1.2 Product Description 111
9.8.1.3 Product Status
111
9.8.1.4 Product Milestone 111
10 GlaxoSmithKline plc Company
Profile 113
10.1 Company Overview 113
10.2 Business Overview 113
10.2.1 Products 114
10.2.2 History 114
10.3 Locations And Subsidiaries
117
11 Novartis AG Company Profile 119
11.1 Company Overview 119
11.2 Business Overview 119
11.2.1 Major Products and Services 120
11.3
Locations And Subsidiaries 121
12 Regulation System 123
12.1 Medical
Device Registration Protocol 123
12.1.1 Registration Documentation 123
12.1.2 Registration Procedure 124
12.1.3 Medical Device Registration Fee
125
13 Pricing and Reimbursement 126
14 Distribution Structure 127
15 Appendix 128
15.1 Global Markets Direct Research Methodology 128
15.2 Coverage 129
15.3 Secondary Research 129
15.4 Primary Research
130
15.5 Models 130
15.6 Forecasts 131
15.7 Expert Panels 131
15.8 Currency Conversion 132
15.9 Contact Us 133
15.10 Disclaimer
133
1.1 List of Tables
Table 1: Drug Delivery Devices, Brazil,
Overall Revenues ($ mn), 2000-2012 18
Table 2: Drug Delivery Devices,
Brazil, Overall Revenues ($ mn), Historic, 2000-2007 19
Table 3: Drug
Delivery Devices, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 20
Table 4: Drug Delivery Devices, Brazil, Category Revenues ($ mn), 2000-2012
21
Table 5: Drug Delivery Devices, Brazil, Category Revenues ($ mn),
Historic, 2000-2007 22
Table 6: Drug Delivery Devices, Brazil, Category
Revenues ($ mn), Forecast, 2007-2012 23
Table 7: Drug Delivery Devices,
Brazil, Category Volume (Units), 2000-2012 24
Table 8: Drug Delivery
Devices, Brazil, Category Volume (Units), Historic, 2000-2007 25
Table 9:
Drug Delivery Devices, Brazil, Category Volume (Units), Forecast, 2007-2012
26
Table 10: Drug Delivery Devices, Brazil, Company Share by Revenue ($
mn), 2005-2006 27
Table 11: Inhalation Systems, Brazil, Overall Revenues
($ mn), Historic, 2000-2007 28
Table 12: Inhalation Systems, Brazil,
Overall Revenues ($ mn), Forecast, 2007-2012 29
Table 13: Inhalation
Systems, Brazil, Revenue by Segment ($ mn), Historic, 2000-2007 30
Table
14: Inhalation Systems, Brazil, Revenue by Segment ($ mn), Forecast, 2007-2012
31
Table 15: Metered Dose Inhaler Devices, Brazil, Overall Revenues ($
mn), Historic, 2000-2007 32
Table 16: Metered Dose Inhaler Devices,
Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 33
Table 17: Dry
Powder Inhaler Devices, Brazil, Overall Revenues ($ mn), Historic, 2000-2007
34
Table 18: Dry Powder Inhaler Devices, Brazil, Overall Revenues ($ mn),
Forecast, 2007-2012 35
Table 19: Inhalation Systems, Brazil, Overall
Volume (Units), Historic, 2000-2007 36
Table 20: Inhalation Systems,
Brazil, Overall Volume (Units), Forecast, 2007-2012 37
Table 21: Metered
Dose Inhaler Devices, Brazil, Overall Volume (Units), Historic, 2000-2007
38
Table 22: Metered Dose Inhaler Devices, Brazil, Overall Volume (Units),
Forecast, 2007-2012 39
Table 23: Dry Powder Inhaler Devices, Brazil,
Overall Volume (Units), Historic, 2000-2007 40
Table 24: Dry Powder
Inhaler Devices, Brazil, Overall Volume (Units), Forecast, 2007-2012 41
Table 25: Metered Dose Inhaler Devices, Brazil, Average Price ($), Historic,
2000-2007 42
Table 26: Metered Dose Inhaler Devices, Brazil, Average Price
($), Forecast, 2007-2012 43
Table 27: Dry Powder Inhaler Devices, Brazil,
Average Price ($), Historic, 2000-2007 44
Table 28: Dry Powder Inhaler
Devices, Brazil, Average Price ($), Forecast, 2007-2012 45
Table 29:
Inhalation Systems, Brazil, Distribution Share by Revenue ($ mn), 2005-2006
46
Table 30: Inhalation Systems, Brazil, Company Share by Revenue ($ mn),
2005-2006 47
Table 31: Infusion Systems, Brazil, Overall Revenues ($ mn),
Historic, 2000-2007 48
Table 32: Infusion Systems, Brazil, Overall
Revenues ($ mn), Forecast, 2007-2012 49
Table 33: Infusion Systems,
Brazil, Revenue by Segment ($ mn), Historic, 2000-2007 50
Table 34:
Infusion Systems, Brazil, Revenue by Segment ($ mn), Forecast, 2007-2012
51
Table 35: Infusion Disposable Sets, Brazil, Overall Revenues ($ mn),
Historic, 2000-2007 52
Table 36: Infusion Disposable Sets, Brazil, Overall
Revenues ($ mn), Forecast, 2007-2012 53
Table 37: Infusion Pumps, Brazil,
Overall Revenues ($ mn), Historic, 2000-2007 54
Table 38: Infusion Pumps,
Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 55
Table 39: Syringe
Pumps, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 56
Table 40:
Syringe Pumps, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 57
Table 41: Infusion Systems, Brazil, Overall Volume (Units), Historic,
2000-2007 58
Table 42: Infusion Systems, Brazil, Overall Volume (Units),
Forecast, 2007-2012 58
Table 43: Infusion Disposable Sets, Brazil, Overall
Volume (Units), Historic, 2000-2007 59
Table 44: Infusion Disposable Sets,
Brazil, Overall Volume (Units), Forecast, 2007-2012 60
Table 45: Infusion
Pumps, Brazil, Overall Volume (Units), Historic, 2000-2007 61
Table 46:
Infusion Pumps, Brazil, Overall Volume (Units), Forecast, 2007-2012 62
Table 47: Syringe Pumps, Brazil, Overall Volume (Units), Historic, 2000-2007
63
Table 48: Syringe Pumps, Brazil, Overall Volume (Units), Forecast,
2007-2012 64
Table 49: Infusion Pumps, Brazil, Average Price ($),
Historic, 2000-2007 65
Table 50: Infusion Pumps, Brazil, Average Price
($), Forecast, 2007-2012 66
Table 51: Syringe Pumps, Brazil, Average Price
($), Historic, 2000-2007 67
Table 52: Syringe Pumps, Brazil, Average Price
($), Forecast, 2007-2012 68
Table 53: Infusion Disposable Sets, Brazil,
Average Price ($), Historic, 2000-2007 69
Table 54: Infusion Disposable
Sets, Brazil, Average Price ($), Forecast, 2007-2012 70
Table 55: Infusion
Systems, Brazil, Distribution Share by Revenue ($ mn), 2005-2006 71
Table
56: Infusion Systems, Brazil, Company Share by Revenue ($ mn), 2005-2006
72
Table 57: AstraZeneca PLC, Subsidiaries 77
Table 58:
AstraZeneca PLC, Subsidiaries(Contd..) 78
Table 59: 3M Company, SWOT
Analysis, 2006 87
Table 60: 3M Company, Revenue by Segment, USD
Million, 2003-2007 90
Table 61: 3M Company, Revenue by Geography, USD
Million, 2003-2007 91
Table 62: 3M Company, Financial Statements, USD
Million, 2003-2007 92
Table 63: 3M Company, Financial Ratios, USD
Million, 2003-2007 93
Table 64: 3M Company, Subsidiaries 94
Table
65: Baxter International Inc., SWOT Analysis, 2006 102
Table 66:
Baxter International Inc., Revenue by Segment, USD Million, 2003-2007 105
Table 67: Baxter International Inc., Revenue by Geography, USD Million,
2003-2007 106
Table 68: Baxter International Inc., Financial
Statements, USD Million, 2003-2007 107
Table 69: Baxter International
Inc., Financial Ratios, USD Million, 2003-2007 108
Table 70: Baxter
International Inc., Other Locations 109
Table 71: Baxter
International Inc., Subsidiaries 110
Table 72: GlaxoSmithKline plc,
Subsidiaries 117
Table 73: GlaxoSmithKline plc, Subsidiaries(Contd..)
118
Table 74: Novartis Medical Nutrition, Other Locations 121
Table 75: Novartis Medical Nutrition, Other Locations(Contd..) 122
Table 76: Medical Device Registration Fee in Brazil, 2002 125
Table 77:
Currency Conversion from USD to Local Currency at 2007 Constant Rate 132
1.2 List of Figures
Figure 1: Health Expenditure by Source in Brazil,
1996 17
Figure 2: Drug Delivery Devices, Brazil, Overall Revenues ($ mn),
2000-2012 18
Figure 3: Drug Delivery Devices, Brazil, Overall Revenues ($
mn), Historic, 2000-2007 19
Figure 4: Drug Delivery Devices, Brazil,
Overall Revenues ($ mn), Forecast, 2007-2012 20
Figure 5: Drug Delivery
Devices, Brazil, Category Revenues ($ mn), 2000-2012 21
Figure 6: Drug
Delivery Devices, Brazil, Category Revenues ($ mn), Historic, 2000-2007 22
Figure 7: Drug Delivery Devices, Brazil, Category Revenues ($ mn), Forecast,
2007-2012 23
Figure 8: Drug Delivery Devices, Brazil, Category Volume
(Units), 2000-2012 24
Figure 9: Drug Delivery Devices, Brazil, Category
Volume (Units), Historic, 2000-2007 25
Figure 10: Drug Delivery Devices,
Brazil, Category Volume (Units), Forecast, 2007-2012 26
Figure 11: Drug
Delivery Devices, Brazil, Company Share (%), 2006 27
Figure 12: Inhalation
Systems, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 28
Figure
13: Inhalation Systems, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012
29
Figure 14: Inhalation Systems, Brazil, Revenue by Segment ($ mn),
Historic, 2000-2007 30
Figure 15: Inhalation Systems, Brazil, Revenue by
Segment ($ mn), Forecast, 2007-2012 31
Figure 16: Metered Dose Inhaler
Devices, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 32
Figure
17: Metered Dose Inhaler Devices, Brazil, Overall Revenues ($ mn), Forecast,
2007-2012 33
Figure 18: Dry Powder Inhaler Devices, Brazil, Overall
Revenues ($ mn), Historic, 2000-2007 34
Figure 19: Dry Powder Inhaler
Devices, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 35
Figure
20: Inhalation Systems, Brazil, Overall Volume (Units), Historic, 2000-2007
36
Figure 21: Inhalation Systems, Brazil, Overall Volume (Units),
Forecast, 2007-2012 37
Figure 22: Metered Dose Inhaler Devices, Brazil,
Overall Volume (Units), Historic, 2000-2007 38
Figure 23: Metered Dose
Inhaler Devices, Brazil, Overall Volume (Units), Forecast, 2007-2012 39
Figure 24: Dry Powder Inhaler Devices, Brazil, Overall Volume (Units),
Historic, 2000-2007 40
Figure 25: Dry Powder Inhaler Devices, Brazil,
Overall Volume (Units), Forecast, 2007-2012 41
Figure 26: Metered Dose
Inhaler Devices, Brazil, Average Price ($), Historic, 2000-2007 42
Figure
27: Metered Dose Inhaler Devices, Brazil, Average Price ($), Forecast,
2007-201 2 43
Figure 28: Dry Powder Inhaler Devices, Brazil, Average Price
($), Historic, 2000-2007 44
Figure 29: Dry Powder Inhaler Devices, Brazil,
Average Price ($), Forecast, 2007-2012 45
Figure 30: Inhalation Systems,
Brazil, Distribution Share (%), 2006 46
Figure 31: Inhalation Systems,
Brazil, Company Share (%), 2006 47
Figure 32: Infusion Systems, Brazil,
Overall Revenues ($ mn), Historic, 2000-2007 48
Figure 33: Infusion
Systems, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 49
Figure
34: Infusion Systems, Brazil, Revenue by Segment ($ mn), Historic, 2000-2007
50
Figure 35: Infusion Systems, Brazil, Revenue by Segment ($ mn),
Forecast, 2007-2012 51
Figure 36: Infusion Disposable Sets, Brazil,
Overall Revenues ($ mn), Historic, 2000-2007 52
Figure 37: Infusion
Disposable Sets, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 53
Figure 38: Infusion Pumps, Brazil, Overall Revenues ($ mn), Historic,
2000-2007 54
Figure 39: Infusion Pumps, Brazil, Overall Revenues ($ mn),
Forecast, 2007-2012 55
Figure 40: Syringe Pumps, Brazil, Overall Revenues
($ mn), Historic, 2000-2007 56
Figure 41: Syringe Pumps, Brazil, Overall
Revenues ($ mn), Forecast, 2007-2012 57
Figure 42: Infusion Disposable
Sets, Brazil, Overall Volume (Units), Historic, 2000-2007 59
Figure 43:
Infusion Disposable Sets, Brazil, Overall Volume (Units), Forecast, 2007-2012
60
Figure 44: Infusion Pumps, Brazil, Overall Volume (Units), Historic,
2000-2007 61
Figure 45: Infusion Pumps, Brazil, Overall Volume (Units),
Forecast, 2007-2012 62
Figure 46: Syringe Pumps, Brazil, Overall Volume
(Units), Historic, 2000-2007 63
Figure 47: Syringe Pumps, Brazil, Overall
Volume (Units), Forecast, 2007-2012 64
Figure 48: Infusion Pumps, Brazil,
Average Price ($), Historic, 2000-2007 65
Figure 49: Infusion Pumps,
Brazil, Average Price ($), Forecast, 2007-2012 66
Figure 50: Syringe
Pumps, Brazil, Average Price ($), Historic, 2000-2007 67
Figure 51:
Syringe Pumps, Brazil, Average Price ($), Forecast, 2007-2012 68
Figure
52: Infusion Disposable Sets, Brazil, Average Price ($), Historic, 2000-2007
69
Figure 53: Infusion Disposable Sets, Brazil, Average Price ($),
Forecast, 2007-2012 70
Figure 54: Infusion Systems, Brazil, Distribution
Share (%), 2006 71
Figure 55: Infusion Systems, Brazil, Company Share (%),
2006 72
Figure 56: 3M Company, Value Chain Analysis 85
Figure 57:
Baxter International Inc., Value Chain Analysis 100
Figure 58: Global
Markets Direct Methodology 128
|
